Back

Effects of exercise training type and duration in patients with peripheral artery disease: a randomised controlled trial

20 April 2018 (15:30 - 16:30)
Organised by:
Congress Presentation Part of: Moderated Poster Session IV Cardiovascular Rehabilitation EAPC Premium Access EuroPrevent 2018

About the speaker

Photo
Doctor Marko Novakovic

University Medical Centre Ljubljana, Ljubljana (Slovenia)

8 More presentations in this session

Presentation thumbnail
Ventricular assist device implantation is associated with higher levels of physical activity in patients with advanced heart failure
Mr N. Moreno Suarez (Perth, AU)
Abstract Slides
Presentation thumbnail
Respiratory muscle weakness predicts all-cause mortality in chronic heart failure patients with preserved left ventricular ejection fraction
Mr N. Hamazaki (Sagamihara, JP)
Abstract Slides
Presentation thumbnail
Inverse association between cardiorespiratory fitness estimated by a 1-km moderate treadmill walk and mortality in hypertensive patients with cardiovascular disease
Doctor N. Sorino (Bologna, IT)
Abstract Slides
Presentation thumbnail
Successful diabetes prevention - the Prevention First longitudinal study (PFLS)
Doctor J. Scholl (Rudesheim am Rhein, DE)
Abstract Slides
Presentation thumbnail
Effectiveness of CHA2DS2-VASc based decision support on stroke prevention in atrial fibrillation: A cluster randomized trial in general practice
Doctor S. van Doorn (Utrecht, NL)
Abstract

Access the full session

Session thumbnail
Moderated Poster Session IV

The Event

Event poster

EuroPrevent 2018

20 April 2018 15:30 CET
You may be interested in
thumbnail
Congress Presentation
New biomarkers in peripheral artery disease cardiovascular rehabilitation - keep it simple
13 April 2023
thumbnail
Congress Presentation
Impact of different exercise training modalities on patient-reported outcomes in heart failure with reduced and preserved ejection fraction
23 April 2026
thumbnail
Congress Presentation
Effects of semaglutide on functional capacity in patients with type 2 diabetes and peripheral arterial disease: rationale and design of the STRIDE trial
27 August 2021
thumbnail
Congress Presentation
Effect of behaviour change interventions on walking capacity, clinical outcomes, and quality of life in intermittent claudication: insights from the OPTIMA systematic review and meta-analysis
30 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources